AbCellera Presents at UBS Biopharma Conference

Cover art for AbCellera Presents at UBS Biopharma Conference

TL;DR: AbCellera's CEO highlights antibody platform progress targeting GPCRs and ion channels at UBS conference. AbCellera CEO shares antibody tech advances at UBS Global Biopharma Conference 2026. Carl L. Hansen, CEO, President & Chairperson of AbCellera Biologics Inc. (ABCL) presented at UBS Global Biopharma Conference 2026. AbCellera's 14-year platform targets GPCRs, ion channels, and T-cell engagers with best-in-world technology.

Nov 17, 2026

From · · 30s

TL;DR: AbCellera Presents at UBS Biopharma Conference

AbCellera CEO shares antibody tech advances at UBS Global Biopharma Conference 2026.

AbCellera's CEO highlights antibody platform progress targeting GPCRs and ion channels at UBS conference. AbCellera CEO shares antibody tech advances at UBS Global Biopharma Conference 2026. Carl L. Hansen, CEO, President & Chairperson of AbCellera Biologics Inc. (ABCL) presented at UBS Global Biopharma Conference 2026. AbCellera's 14-year platform targets GPCRs, ion channels, and T-cell engagers with best-in-world technology.

  • AbCellera CEO
  • Antibody Platform Focus
  • Biotech Business Model

Read the story version — the same reporting as a swipeable deck of 3 cards.

Read the original on Seekingalpha

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on abcellera and related topics.